Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...
Reexamination Certificate
2004-04-14
2008-08-05
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Hormone or other secreted growth regulatory factor,...
C514S012200
Reexamination Certificate
active
07407660
ABSTRACT:
The invention provides methods and compositions for modulating vascularization and angiogenesis, including selective modulation of stages of multi-step vascularization and angiogenesis.
REFERENCES:
patent: 5468634 (1995-11-01), Liu
patent: 5547856 (1996-08-01), Godowski et al.
patent: 5733876 (1998-03-01), O'Reilly et al.
patent: 5871697 (1999-02-01), Rothberg et al.
patent: 6099841 (2000-08-01), Hillan et al.
patent: 6365572 (2002-04-01), Stilz et al.
patent: 2002/0042372 (2002-04-01), Olsen et al.
patent: 93/23075 (1993-11-01), None
patent: 97/30065 (1997-08-01), None
patent: 98/31709 (1998-07-01), None
patent: 00/52051 (2000-09-01), None
patent: 00/55174 (2000-09-01), None
patent: WO 01/30969 (2001-05-01), None
patent: WO 01/32926 (2001-05-01), None
patent: 01/73025 (2001-10-01), None
Bussolino et al., “Hepatocyte Growth Factor is a Potent Angiogenic Factor Which Stimulates Endothelial Cell Motility and Growth”Journal of Cell Biology119(3) :629-641 (Nov. 1992).
Couffinhal et al., “Animal Model: Mouse Model of Angiogenesis”American Journal of Pathology152(6) :1667-1679 (1998).
Ferrara, N., “Role of Vascular Endothelial Growth Factor in Physiologic and Pathologic Angiogenesis: Therapeutic Implications”Seminars on Oncology29(6) :Suppl. 16:10-14 (2002).
Filvaroff et al., “Stanniocalcin 1 Alters Muscle and Bone Structure and Function in Transgenic Mice”Endocrinology143(9) :3681-3690 (2002).
Folkman, J., “Role of Angiogenesis in Tumor Growth and Metastasis”Seminars in Oncology26(6) :Suppl. 16:15-18 (2002).
Freund, Y.R. and Blair, P.B., “Depression of Natural Killer Activity and Mitogen Responsiveness in Mice Treated with Pristane”J. Immunol.129:2826-2830 (1982).
Fujiwara et al., “Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers”Int. J. Oncol.16:799-804 (2000).
Gerritsen et al., “In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set”Physiol. Genomics10(1) :13-20 (2002).
Hayashi et al., “Potential Role of Hepatocyte Growth Factor, a Novel Angiogenic GRowth Factor, in Peripheral Arterial Disease”Circulation100(19 Suppl) :II-301-II-308 (1999).
Hongo, J.S. et al., “Development and Characterization of Murine Monoclonal Antibodies to the Latency-Associated Peptide of Transforming Growth Factor β1”Hybridoma14:253-260 (1995).
Ito et al., “Angiogenesis but not collateral growth associated with ischemia after femoral artery occlusion”Am. J. Physiol.273(3 Pt 2) :H1255-H1265 (1997).
Jennische et al., “Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle”Am J Physiol265 (1 Pt 1) :C122-C128 (1993).
Kahn et al., “Gene Expression Profiling in an in Vitro Model of Angiogenesis”American Journal of Pathology156 (6) :1887-1900 (2000).
Kohler and Milstein., “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity.”Nature. 256:495-497 (Aug. 7, 1975).
Koide et al., “Preparation of a Monoclocal Antibody Specific for Human Stanniocalcin”Biol. Pharm. Bull.21(12) :1352-1355 (1998).
Maulik et al., “Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition”Cytokine&Growth Factor Reviews13:41-59 (2002).
McCudden et al., “Characterization of Mammalian Stanniocalcin Receptors”Journal of Biological Chemistry277:45249-45258 (2002).
Miyazawa et al., “Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor”Biochem.&Biophys. Res. Comm. 163(2) :967-973 (Sep. 15, 1989).
Morishita et al., “Hepatocyte Growth Factor as Cardiovascular Hormone: Role of HGF in the Pathogenesis of Cardiovascular Disease”Endocrine Journal49:273-284 (2002).
Nakamura et al., “Molecular Cloning and Expression of Human Hepatocyte Growth Factor”Nature342:440-443 (Nov. 23, 1999).
Okajima et al., “Primary Structure of Rat Hepatocyte Growth Factor and Induction of Its mRNA During Liver Regeneration Following Hepatic Injury”European Journal of Biochemistry193:375-381 (1990).
Paciga et al., “Ovarian Stanniocalcin Is Structurally Unique in Mammals and Its Production and Release Are Regulated through the Luteinizing Hormone Receptor”Endocrinology143:3925-3934 (2002).
To et al., “The roles of hepatocyte growth factor/scatter factor and Met receptor in human cancers (Review)”Oncol Rep5(5) :1013-1024 (1998).
Schmidt et al., “Levels of Vascular Endothelial Growth Factor, Hepatocyte Growth Factor/Scatter Factor and Basic Fibroblast Growth Factor in Human Gliomas and Their Relation to Angiogenesis”Int. J. Cancer84(1) :10-18 (1999).
Scholz et al., “Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (artereiogenesis)”Virchows Arch436(3) :257-70 (2000).
Seki et al., “Isolation and Expression of cDNA for Different Forms of Hepatocyte Growth Factor from Human Leukocyte”Biochem. and Biophys. Res. Commun.172(1) :321-327 (Oct. 15, 1990).
Tashiro et al., “Deduced Primary Structure of Rat Hepatocyte Growth Factor and Expression of the mRNA in Rat Tissues”Proc. Natl. Acad. Sci. USA87:3200-3204 (1990).
Varghese et al., “Overexpression of Human Stanniocalcin Affects Growth and Reproduction in Transgenic Mice”Endocrinology143 :868-876 (2002).
Wagner et al., “Human Stanniocalcin Inhibits Renal Phosphate Excretion in the Rat”Journal of Bone and Mineral Research12(2) :165-171 (1997).
Wagner et al., “Molecular cloning and cDNA sequence analysis of coho salmon stanniocalcin”Molecular and Cellular Endocrinology90(1) :7-15 (1992).
Wagner et al., “Purification, Characterization, and Bioassay of Teleocalcin, a Glycoprotein from Salmon Corpuscles of Stannius”General and Comparative Endocrinology63:481-491 (1986).
Xin et al., “Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro an in Vivo”Am. J. Pathol.158(3) :1111-1120 (2001).
Zlot et al., “Stanniocalcin 1 Is an Autocrine Modulator of Endothelial Angiogenic Responses to Hepatocyte Growth Factor”The Journal of Biological Chemistry278(48) :47654-47659 (2003).
Adams, R.H., et al., “Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis”Genes and Development13(3) :295-306 (1999).
Airenne, T., GenBank Accession No. U31201, record created Apr. 27, 1996.
Alberts et al.Molecular Biology of the Cell, 3RD edition, New York:Garland Publishing, Inc. pp. 465 (1994).
Amieva, M.R. et al., “Subcellular Localization of Moesin in Dynamic Filopodia, Retraction Fibers, and Other Structures Involved in Substrate Exploration, Attachment, and Cell-Cell Contacts”Exp. Cell Res.219(1) :180-196 (1995).
Antonarakis, S.E., GenBank Accession No. X91249, record created Aug. 21, 1996.
Arch, R.H. et al., “4-1BB and Ox40 Are Members of a Tumor Necrosis Factor (TNF) -Nerve Growth Factor Receptor Subfamily That Bind TNF Receptor-Associated Factors and Activate Nuclear Factor κB”Mol Cell Biol18(1) :558-565 (Jan. 1998).
Arnman, V. et al., “Interferon-γ modulates the fibrinolytic response in cultured human endothelial cells”Thrombosis Research77(5) :431-440 (1995).
Arpin, M. et al., “Functional differences between L- and T-plastin isoforms”Journal of Cell Biology127 (6 Pt 2) :1995-2008 (2004).
Avanzi, G., et al., “GAS6 Inhibits Granulocyte Adhesion to Endothelial Cells”Blood91 (7) :2334-40 (1998).
Baum et al., “Identification of OX40 ligand and Preliminary Characterization of its Activities on OX40 receptor”Circ. Shock44(1) :30-34. (1994).
Baum, P.R., et al., GenBank A
Gerritsen Mary E.
Hongo Jo-Anne S.
Zlot Constance H.
Fang Carol A.
Genentech Inc.
Genentech, Inc.
Li Ruixiang
LandOfFree
Methods and compositions for selective modulation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for selective modulation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for selective modulation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4010730